Intas, India issued USFDA Warning letter
Intas facility was inspected by FDA investigators Jose E Melendez, Justin A Boyd, Pratik S
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
